glp1.how

What obesity actually is: history, diagnosis, and why medicine calls it a chronic disease

The formula used to diagnose obesity was invented in the 1830s by an astronomer studying populations, not patients — and a lot of what we assume about obesity rests on tools and ideas never designed for the job. Here's what obesity actually is: how the definition moved from moral failing to medical diagnosis, how it's diagnosed today, why major medical bodies classify it as a disease, why 'chronic' is the key word, and where the stigma comes from.

Updated Jul 16, 2026

The formula used to decide whether you have obesity was invented in the 1830s by a Belgian astronomer. Adolphe Quetelet was studying populations, not patients — he wanted a mathematical description of the "average man," and dividing weight by height squared gave him a tidy way to do it. He never meant it to measure any individual's health, and it didn't even get the name "body mass index" until 1972. Yet nearly two centuries later, that same ratio is still the number on the chart that sorts people into "normal," "overweight," and "obese."

Starting there tells you something important: a lot of what we assume about obesity is built on tools and ideas that were never designed for the job. Understanding what obesity actually is — how it's diagnosed, why medicine now calls it a disease, and why "chronic" is the key word — means untangling the science from a century of moral baggage.

From moral failing to medical diagnosis

For most of the twentieth century, obesity wasn't treated as a medical condition at all. It was treated as a character problem: eat less, move more, and if you couldn't, that was a failure of willpower. Medicine largely went along with it, which is why "treatment" for decades meant being told to try harder.

That framing began to shift as the biology accumulated. In 2013 the American Medical Association formally recognized obesity as a disease — a contested vote at the time, but a turning point. It said, in effect, that obesity is a medical condition with biological drivers, not simply the sum of a person's choices.

The most rigorous step came in 2025, when a global commission of 58 experts — published in The Lancet Diabetes & Endocrinology and endorsed by 76 medical organizations worldwide — proposed a complete overhaul of how obesity is defined and diagnosed.

How obesity is actually diagnosed

Here's where the Quetelet problem comes back. BMI is cheap, fast, and genuinely useful across large populations — but at the level of one human being it's crude. It can't tell muscle from fat, it doesn't see where fat sits (the visceral fat around your organs is the dangerous kind), and its cutoffs don't translate cleanly across age, sex, or ethnicity. A muscular athlete and a sedentary person can share a BMI; so can two people in very different health.

The 2025 Lancet commission's answer was to stop using BMI as a diagnosis on its own. It recommends BMI be treated as a screening signal, with actual excess body fat confirmed by a direct measurement or at least one additional measure such as waist circumference. More importantly, it splits obesity into two states:

  • Preclinical obesity — excess fat, but organs and tissues still working normally. A risk state, not an illness in itself.
  • Clinical obesity — excess fat that is already impairing how the body works, with signs, symptoms, or organ damage that trace back to the adiposity itself.

That distinction matters because it aims treatment at the people whose health is actually affected, rather than at a number on a chart.

Why it counts as a disease

The case for calling obesity a disease rests on what excess adiposity does inside the body. In clinical obesity, fat tissue isn't inert padding — it behaves like a dysfunctional organ, disrupting hormones, inflammation, blood sugar, blood pressure, and cardiovascular function, and it can cause life-altering, sometimes life-threatening damage like heart attack, stroke, and organ failure. That is the definition of a disease: a condition that impairs the body's normal function.

The deeper point is that body weight is biologically regulated, not freely chosen. The body defends a weight range through hunger and satiety hormones, energy expenditure, and brain circuitry — the same systems the GLP-1 medications act on. This is why "just eat less" so reliably fails as a long-term prescription: it asks someone to consciously override a homeostatic system built to resist exactly that.

Why "chronic" is the whole point

If there's one word to take from all of this, it's chronic.

When someone loses weight, the body doesn't accept the new number as the target. It responds much the way it would to starvation — appetite hormones rise, metabolism slows, the drive to eat increases — and those adaptations can persist long after the weight is gone. The regain that so often follows a diet isn't evidence of weakness; it's the predictable result of a body doing its job.

That's what makes obesity a chronic, relapsing condition rather than a problem you solve once. It's also why the medications are understood as long-term treatment: stop them, and the underlying biology that was being managed returns, along with the weight. You don't treat high blood pressure for three months and call it cured — obesity works the same way. (Our guide on what to realistically expect on a GLP-1 gets into this directly.)

The stigma that sits on top of the science

None of this happens in a vacuum. Weight stigma — the assumption that body size reflects discipline or worth — is pervasive, and it isn't just unpleasant. A 2020 international consensus statement in Nature Medicine, backed by dozens of scientific organizations, laid out the evidence that weight stigma causes real physical and psychological harm and makes people less likely to receive good medical care. People avoid appointments; clinicians attribute unrelated symptoms to weight and miss the actual problem.

This is where the science and the framing connect. Recognizing obesity as a biologically driven disease isn't only a technical reclassification — it's a direct challenge to the "just try harder" narrative that fuels the stigma in the first place. (For the deeper argument on why that framing shapes everything from insurance to how you're treated in an exam room, see Obesity as a chronic disease vs. a lifestyle choice; for handling bias in clinical settings, see Weight stigma in healthcare settings.)

The bottom line

Obesity is defined by excess body fat that harms health — increasingly diagnosed by more than BMI alone, and now separated into a risk state (preclinical) and an actual illness (clinical). Major medical bodies classify it as a disease because it impairs how the body functions and is driven by biology the individual doesn't consciously control. And it is chronic: the body actively defends its weight, which is why durable treatment looks like ongoing management, not a one-time fix. The moral framing that dominated the last century isn't just unkind — it's a poor description of what the science actually shows.

obesitychronic-diseasediagnosisbmistigmaadiposityoverviewtreatment

Was this helpful?

Common questions

Questions people often ask about this topic.

  • Is obesity officially recognized as a disease?

    Yes. The American Medical Association formally recognized obesity as a disease in 2013, and a 2025 global commission in The Lancet Diabetes & Endocrinology — endorsed by 76 medical organizations — further defined 'clinical obesity' as a chronic systemic illness. The basis is that excess adiposity impairs the normal function of organs and tissues, which is what defines a disease.

  • Why is BMI considered a flawed way to diagnose obesity?

    BMI was devised in the 1830s to describe populations, not to assess individual health. It can't distinguish muscle from fat, ignores where fat is stored, and uses cutoffs that don't translate cleanly across age, sex, and ethnicity. The 2025 Lancet commission recommends using BMI only as a screening signal and confirming excess body fat with a direct measure or something like waist circumference.

  • What's the difference between preclinical and clinical obesity?

    Preclinical obesity is excess body fat while organs and tissues still function normally — a risk state rather than an illness. Clinical obesity is excess fat that is already impairing how the body works, with signs, symptoms, or organ damage caused by the adiposity. The distinction targets treatment at the people whose health is actually affected.

  • Why is obesity called a chronic disease instead of something you can just fix?

    Because the body biologically defends its weight. After weight loss, appetite hormones rise and metabolism slows — adaptations that can persist and drive regain. That makes obesity a chronic, relapsing condition, and it's why treatments like GLP-1 medications are used as long-term management: stop them and the underlying biology, and the weight, tend to return.

  • Is obesity caused by a lack of willpower?

    No. Body weight is regulated by hunger and satiety hormones, energy expenditure, and brain circuitry that resist weight loss — the same systems GLP-1 medications act on. That's why 'just eat less' fails as a long-term prescription, and it's a central reason weight stigma, which frames body size as a matter of discipline, is both inaccurate and harmful.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

2Supporting

  • Definition and diagnostic criteria of clinical obesity

    The Lancet Diabetes & Endocrinology (Rubino et al., 2025) — via PubMed · Clinical guideline

    Landmark 2025 commission (58 experts, endorsed by 76 organizations): defines clinical vs preclinical obesity as a chronic systemic illness, and recommends BMI be used as a screening signal only, not an individual diagnosis. Anchors the diagnosis, disease-classification, and chronic sections.

  • Joint international consensus statement for ending stigma of obesity

    Nature Medicine (Rubino et al., 2020) — via PubMed · Clinical guideline

    Multidisciplinary international consensus: reviews evidence that weight stigma causes physical and psychological harm and reduces quality of care, and calls for a new public narrative about obesity. Anchors the stigma section.

Related guides

  • Can you boost GLP-1 naturally? How food and lifestyle compare to the medicationsYou can raise your own GLP-1 with protein, fermentable fiber, and exercise — that part is real. What doesn't hold up is the implied equivalence with the medications. Here's what actually nudges your natural GLP-1, why your body clears it in minutes while the drugs hold it for a week, and why "natural boosting" is a foundation rather than a replacement.
  • New to GLP-1? Start here: your step-by-step learning pathJust starting out with GLP-1 medications, or still deciding? This ordered path walks you from how these medications work through access, side effects, eating well, protecting muscle, tracking progress, and the mental and social side — one step at a time.
  • Common GLP-1 side effects and how to manage themMost GLP-1 side effects are digestive, worst right after a dose increase, and manageable with a few practical habits. Here's what to expect, what actually helps with nausea and constipation, and the red-flag symptoms that mean call a doctor now rather than wait it out.
  • What to realistically expect on a GLP-1The medication doesn't work like a switch. Here's the realistic arc: weeks of dose titration before much happens, roughly 1-2 lb of loss a week once you're up to dose, wide variation between fast and slow responders, an expected plateau, and the part people skip — it's a long-term treatment, not a course you finish.
  • How GLP-1 medications work, in plain languageSemaglutide and tirzepatide copy hormones your gut already makes after a meal. Here's what those hormones do, why the medications quiet hunger and 'food noise,' what the second hormone in tirzepatide adds, and why 'it slows your stomach' explains both the appetite drop and the nausea.
  • What is suppression, satiation, and satiety on a GLP-1?GLP-1 medications change appetite through three related but distinct mechanisms — suppression, satiation, and satiety. Here's what each means and what to expect.